In Vitro-based and in Vivo-based Simulations of Benzene Uptake and Metabolism in Rats

Alternatives to Laboratory Animals

Volumn 24, Issue 2, 1996, Pages 179-190

  De Jongh, Joost ^a   Blaauboer, Bas J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Benzene; Biotransformation; In vitro in vivo extrapolation; Metabolism; PBPK models; Simulations

Indexed keywords

EID: 0000047052     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ramsey, J.C. & Andersen, M.E. (1984) A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 73, 159-175.
2. Andersen, M.E. (1991). Physiological modelling of organic compounds. Annals of Occupational Hygiene 35, 309-321
3. Leung, H.W. (1991). Development and utilization of physiologically based models for toxicological applications. Journal of Toxicology and Environmental Health 32, 247-267.
4. Clewell, H.J. (1993). Coupling of computer modelling with in vitro methodologies to reduce animal usage in toxicity testing. Toxicology Letters 68, 101-117.
5. Johanson, G. (1993). Use of toxicokinetics in risk assessment based on in vitro data. ATLA 21, 173-180.
6. Sato, A. & Nakajima, T. (1979). A structure-activity relationship of some chlorinated hydrocarbons. Archives of Environmental Health, March/April, 69-75
7. Gargas, M.L., Burgess, R.J., Voisard, D.E , Cason, G.H. & Andersen, M.E. (1989). Partition coefficients of low molecular-weight volatile chemicals in various liquids and tissues. Toxicology and Applied Pharmacology 98, 87-99.
8. Gearhart, J.M., Jepson, G W., Clewell, H.J., Andersen, M.E. & Conolly, R.B. (1990). Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate, Toxicology and Applied Pharmacology 106, 295-310.
9. Kedderis, G.L., Carfagna, M.A., Held, S.D., Batra, R., Murphy, J.E. & Gargas, M.L. (1993). Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicology and Applied Pharmacology 123, 274-282.
10. Rinski, R.A., Smith, A.B., Hornung, R., Fillon, T.G., Young, R J., Okum. A.H. & Landrigan, P.J. (1987). Benzene and leukemia, an epidemiological risk assessment. New England Journal of Medicine 316, 1044-1050.
11. Cox, L.A. (1991). Biological basis of chemical carcinogenesis: insights from benzene. Risk Analysis 11, 453-464.
12. Purcell, K.J., Cason, G.H., Gargas, M.L., Andersen, M.E. & Travis. C.C. (1990). In vivo metabolic interactions of benzene and toluene. Toxicology Letters 52, 141-152
13. Hildebrand, R.L., Andersen, M.E. & Jenkins, L.J. (1981). Prediction of in vivo kinetic constants from kinetic constants measured in vitro. Fundamental and Applied Toxicology 1. 403-409.
14. Nakajima, T., Okino, T. & Sato, A. (1987). Kinetic studies on benzene metabolism in rat liver: possible presence of three forms of benzene metabolising enzymes in the liver. Biochemical Pharmacology 36, 2799-2804.
15. Sato, A. & Nakajima, T. (1979). Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro Toxicology and Applied Pharmacology 48, 249-256
16. 11C]benzene administered orally or by inhalation in rats and mice. Toxicologv and Applied Pharmacology 87, 325-336
17. Schlosser, P.M., Bond, J.A. & Medinski, M.A. (1993). Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis 14, 2477-2486
18. Medinski, M.A., Sabournin, P.J., Lucier, G., Birnbaum, L.S. & Henderson, R F. (1989). A physiological model for simulation of benzene metabolism by rats and mice. Toxicology and Applied Pharmacology 99, 193-206.
19. Travis, C C., Quillen, J.L. & Arms, A.D (1990). Pharmacokinetics of benzene. Toxicology and Applied Pharmacology 99, 400-420.
20. Bois, F.Y., Woodruff, T.J. & Spear, R C. (1991). Comparison of three physiologically based pharmacokinetic models of benzene disposition. Toxicology and Applied Pharmacology 110, 79-88.
21. Spear, R.C., Bois, F.Y , Woodruff, T J , Auslander, D., Parker. J & Selvin, S (1991) Modelling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications. Risk Analysis 11, 641-654.
22. Bois, F.Y., Smith, M.T. & Spear, R.C. (1991). Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism. Toxicology Letters 56, 283-298.
23. Arms, A D. & Travis, C.C. (1988). Reference physiological parameters in pharmacokinetic modeling. U.S. Environmental Protection Agency, EPA 600/688/004.
24. Banks, Y.B, Brewster, D.W. & Birnbaum. L.S. (1990). Age-related changes in dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,4,7,8-pentachlorodibenzofuran. Fundamental and Applied Toxicology 15, 163-173.
25. Andersen, Y.B., Jackson, J.A. & Birnbaum, L S. (1993). Maturational changes in dermal absorption of 2,3,7,8-terachlorodibenzo-p-dioxin (TCDD) in Fischer 344 rats. Toxicology and Applied Pharmacology 119, 214-220.
26. Gargas, M.L., Andersen. M.E, & Clewell, H.J. (1986). A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicology and Applied Pharmacology 86, 341-352.
27. Filser, J G. (1992). The closed chamber technique: uptake, endogenous production, excretion, steady state kinetics and rates of metabolism of gases and vapours. Archives of Toxicology 55, 219-223.
28. Sato, A & Nakajima, T. (1979). A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicology and Applied Pharmacology 47, 41-46.
29. Csanady, G A., Mendrela, A.L., Nolan, R.J. & Filser, J.G. (1994). A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Archives of Toxicology 68, 143-157.